secwatch.observer — SEC 8-K summary
======================================

Issuer:     ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
CIK:        0000879407
Form:       8-K
Filed at:   2025-03-19T23:59:59+00:00
Accession:  0001628280-25-013619
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Arrowhead shareholders elect eight directors, approve executive compensation, ratify KPMG
--------------------------------------------------------------------------------

- All eight director nominees elected with majority support; Douglas Ingram received 68.9M for vs 13.8M against.
- Advisory vote to approve executive compensation passed with 75.3M for, 7.4M against.
- Advisory vote on frequency of future say-on-pay selected 1 year with 79.9M votes.
- Ratification of KPMG as independent auditors approved with 101.0M for, 1.2M against.
- Over 102.7M shares voted out of 125.1M outstanding; all proposals passed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/879407/000162828025013619/0001628280-25-013619-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/879407/000162828025013619/arwr-20250312.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-013619

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer